5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Shree Ganesh Remedies Ltd.

•
ganeshremedies.comBSE: -NSE: SGRL
Market Cap₹ 847 Cr.
Current Price
High / Low₹ 722 / 477
Stock P/E54.9
Book Value₹ 128
Price to Book3.31
Dividend Yield0.00 %
ROCE14.6 %
ROE11.5 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has a healthy return on capital (ROCE) of 24.0%
  • Promoters have been increasing their shareholding - up 3.5pp over 2 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 21.0%
  • Company has consistently been profitable over the last 5 years
  • Operating margins have improved to 31.7% from 25.7%
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.23x)

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Recent results are weak - TTM profit is down 23.1% versus prior year
  • Valuation is stretched - P/E of 54.9 is well above its own 5-year median (30.5)
  • Though reporting repeated profits, the company pays out little dividend (0.0%)
  • Debtor days have increased from 70 to 91
  • Expensive relative to growth - PEG of 2.9

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.SGRL660.0054.89847.280.001.12-67.4914.36-41.7914.6323.34
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
37253227242530213314
20172117151721142214
Operating Profit1781110107107111
OPM %45.35%32.77%34.98%36.60%40.40%29.59%31.73%31.88%34.28%4.12%
1101211111
Interest0000111110
Depreciation2223223332
Profit before Tax16698957492
Tax %22.52%26.54%25.81%27.89%24.86%25.00%26.23%22.36%28.21%26.85%
Net Profit0565735361
10.013.624.974.225.132.683.862.414.880.87

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019Mar 2020Mar 2024Mar 2025Mar 2026TTM
356412610910999
275284697471
Operating Profit91342393528
OPM %24.76%19.55%33.21%36.11%32.04%28.61%
143433
Interest011243
Depreciation126101011
Profit before Tax91438312421
Tax %28.05%22.95%26.34%26.22%26.05%26.36%
Net Profit61028231815
EPS0.000.0021.8917.9713.83—
Dividend Payout %17.99%12.85%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
—
3 Years:
20%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
19%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
—

RETURN ON EQUITY

10 Years:
—
5 Years:
22%
3 Years:
21%
Last Year:
12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2021

Nov 1

1:5

Bonus issue

2020

Aug 18

3:26

Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2020 ,inter alia, to consider and approve In compliance of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that a meeting of the Board of Directors of the Company will be held on Friday, the August 21, 2020 at the registered office of the Company situated at Ankleshwar to consider, amongst other business, the followings; i. To consider and approve Increase in Authorised Share Capital of the Company. ii. To consider and approve the Issue of Bonus Shares. iii. To migrate the Company from SME Platform of BSE Limited to Main Board of BSE Limited. iv. To appoint Mr. Gunjan Chandulal Kothia as Wholetime Director of the Company. v. To appoint of Mr. Parth Chandulal Kothia as Additional Director on the Board of the Company. vi. To fix the Record date for Dividend and Book Closure for AGM. & Increase in Authorised Capital & Bonus issue

Mar 2019Mar 2020Mar 2024Mar 2025Mar 2026
Equity Capital99131313
2533109132150
14303021
Trade Payables45869
34181919
Total Liabilities4155178200213
14208195105
Capital Work in Progress0017812
4351813
76252224
00202233
Cash & Bank12161013
1523152413
Total Assets4155178200213

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019Mar 2020Mar 2024Mar 2025Mar 2026
-55303124
Cash from Investing-0-3-33-36-10
Cash from Financing-0-010-1-12
-517-62

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019Mar 2020Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
69.3370.5072.8072.8072.8072.8072.8072.8472.84
0.010.010.010.010.010.010.000.000.00
0.000.000.000.000.000.000.000.000.52
Government0.000.000.000.000.000.000.000.000.00
30.6629.5027.1927.1927.1927.1927.2027.1626.64

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for SGRL

Loading news…

🤖

AI Stock Analyst

Shree Ganesh Remedies Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login